| Serial monitoring of circulating tumor DNA in patients with primary breast cancer for detection of occult metastatic disease E Olsson, C Winter, A George, Y Chen, J Howlin, MHE Tang, M Dahlgren, ... EMBO molecular medicine 7 (8), 1034-1047, 2015 | 487 | 2015 |
| Whole-genome sequencing of triple-negative breast cancers in a population-based clinical study J Staaf, D Glodzik, A Bosch, J Vallon-Christersson, C Reuterswärd, ... Nature medicine 25 (10), 1526-1533, 2019 | 262 | 2019 |
| Targeting HMG-CoA reductase with statins in a window-of-opportunity breast cancer trial O Bjarnadottir, Q Romero, PO Bendahl, K Jirström, L Rydén, N Loman, ... Breast cancer research and treatment 138, 499-508, 2013 | 249 | 2013 |
| Cyclin D1 overexpression is a negative predictive factor for tamoxifen response in postmenopausal breast cancer patients M Stendahl, Å Kronblad, L Rydén, S Emdin, NO Bengtsson, G Landberg British Journal of Cancer 90 (10), 1942-1948, 2004 | 222 | 2004 |
| A comprehensive approach to rehabilitation interventions following breast cancer treatment-a systematic review of systematic reviews U Olsson Möller, I Beck, L Rydén, M Malmström BMC cancer 19, 1-20, 2019 | 219 | 2019 |
| Anti-estrogen resistance in human breast tumors is driven by JAG1-NOTCH4-dependent cancer stem cell activity BM Simoes, CS O’Brien, R Eyre, A Silva, L Yu, A Sarmiento-Castro, ... Cell reports 12 (12), 1968-1977, 2015 | 199 | 2015 |
| The Sweden Cancerome Analysis Network-Breast (SCAN-B) Initiative: a large-scale multicenter infrastructure towards implementation of breast cancer genomic analyses in the … LH Saal, J Vallon-Christersson, J Häkkinen, C Hegardt, D Grabau, ... Genome medicine 7, 1-12, 2015 | 198 | 2015 |
| High progesterone receptor expression correlates to the effect of adjuvant tamoxifen in premenopausal breast cancer patients M Stendahl, L Rydén, B Nordenskjöld, PE Jönsson, G Landberg, ... Clinical Cancer Research 12 (15), 4614-4618, 2006 | 196 | 2006 |
| Global H3K27 trimethylation and EZH2 abundance in breast tumor subtypes K Holm, D Grabau, K Lövgren, S Aradottir, S Gruvberger-Saal, J Howlin, ... Molecular oncology 6 (5), 494-506, 2012 | 195 | 2012 |
| Adverse Effect of Adjuvant Tamoxifen in Premenopausal Breast Cancer with Cyclin D1 Gene Amplification K Jirström, M Stendahl, L Rydén, A Kronblad, PO Bendahl, O Stål, ... Cancer research 65 (17), 8009-8016, 2005 | 179 | 2005 |
| A high frequency of MDSCs in sepsis patients, with the granulocytic subtype dominating in gram-positive cases H Janols, C Bergenfelz, R Allaoui, AM Larsson, L Rydén, S Björnsson, ... Journal of leukocyte biology 96 (5), 685-693, 2014 | 178 | 2014 |
| Survival and axillary recurrence following sentinel node-positive breast cancer without completion axillary lymph node dissection: the randomized controlled SENOMAC trial J de Boniface, J Frisell, Y Andersson, L Bergkvist, J Ahlgren, L Rydén, ... BMC cancer 17, 1-7, 2017 | 170 | 2017 |
| Systemic monocytic-MDSCs are generated from monocytes and correlate with disease progression in breast cancer patients C Bergenfelz, AM Larsson, K von Stedingk, S Gruvberger-Saal, ... PloS one 10 (5), e0127028, 2015 | 170 | 2015 |
| Prognostic impact of circulating tumor cell apoptosis and clusters in serial blood samples from patients with metastatic breast cancer in a prospective observational cohort S Jansson, PO Bendahl, AM Larsson, KE Aaltonen, L Rydén BMC cancer 16, 1-15, 2016 | 169 | 2016 |
| Clinical value of RNA sequencing–based classifiers for prediction of the five conventional breast cancer biomarkers: a report from the population-based multicenter Sweden … C Brueffer, J Vallon-Christersson, D Grabau, A Ehinger, J Häkkinen, ... JCO Precision Oncology 2, 1-18, 2018 | 168 | 2018 |
| Microenvironmental control of breast cancer subtype elicited through paracrine platelet-derived growth factor-CC signaling P Roswall, M Bocci, M Bartoschek, H Li, G Kristiansen, S Jansson, S Lehn, ... Nature medicine 24 (4), 463-473, 2018 | 166 | 2018 |
| Tumor specific VEGF-A and VEGFR2/KDR protein are co-expressed in breast cancer L Rydén, B Linderholm, NH Nielsen, S Emdin, PE Jönsson, G Landberg Breast cancer research and treatment 82, 147-154, 2003 | 166 | 2003 |
| CA IX is an independent prognostic marker in premenopausal breast cancer patients with one to three positive lymph nodes and a putative marker of radiation resistance DJ Brennan, K Jirstrom, A Kronblad, RC Millikan, G Landberg, MJ Duffy, ... Clinical cancer research 12 (21), 6421-6431, 2006 | 164 | 2006 |
| ERK phosphorylation is linked to VEGFR2 expression and Ets-2 phosphorylation in breast cancer and is associated with tamoxifen treatment resistance and small tumours with good … S Svensson, K Jirström, L Rydén, G Roos, S Emdin, MC Ostrowski, ... Oncogene 24 (27), 4370-4379, 2005 | 149 | 2005 |
| Classification of breast cancer using genetic algorithms and tissue microarrays M Dolled-Filhart, L Rydén, M Cregger, K Jirström, M Harigopal, ... Clinical cancer research 12 (21), 6459-6468, 2006 | 141 | 2006 |
